Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SYRE
SYRE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SYRE News
HighVista Strategies Cuts Stake in Viridian Therapeutics by $7 Million
May 17 2026
Yahoo Finance
Spyre Therapeutics Q1 Earnings Miss Expectations Amid $403M Stock Offering
May 05 2026
seekingalpha
Spyre Therapeutics (SYRE.US) Officer Plans to Sell $5.83 Million in Common Stock via Form 144
May 01 2026
moomoo
Spyre Therapeutics Grants Stock Options to Employees
May 01 2026
Newsfilter
Spyre Therapeutics Prices Public Offering at $62 per Share
Apr 15 2026
NASDAQ.COM
Spyre Therapeutics Upsizes Public Offering to Raise $403 Million
Apr 15 2026
seekingalpha
Spyre Therapeutics Prices $403 Million Public Offering
Apr 15 2026
Yahoo Finance
Spyre Therapeutics Prices Public Offering at $62 per Share
Apr 15 2026
Newsfilter
Spyre Therapeutics Launches $300 Million Public Offering
Apr 14 2026
NASDAQ.COM
Spyre Therapeutics Launches $300M Public Offering to Fund Drug Development
Apr 13 2026
seekingalpha
Spyre Therapeutics Launches $300 Million Public Offering
Apr 13 2026
Newsfilter
Spyre Therapeutics' Trial Data Boosts Stock by 23%
Apr 13 2026
stocktwits
Biotech Stocks Reach New 52-Week Highs
Apr 09 2026
NASDAQ.COM
Spyre Therapeutics CEO Sells Shares Worth $740K
Apr 08 2026
Fool
Spyre Therapeutics CEO Sells Shares Worth $740K
Apr 08 2026
NASDAQ.COM
Spyre Therapeutics Grants Stock Options to Employees
Apr 03 2026
Newsfilter
Show More News
